The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy

by Taylor Morrisette, Sara Alosaimy, Jacinda C. Abdul-Mutakabbir, Razieh Kebriaei, Michael J. Rybak
Published 2020-10-01

Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin

by Jacinda C. Abdul-Mutakabbir, Razieh Kebriaei, Sarah C. J. Jorgensen, Michael J. Rybak
Published 2019-03-01

Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic Mod...

by Jacinda C. Abdul-Mutakabbir, Razieh Kebriaei, Kyle C. Stamper, Zain Sheikh, Philip T. Maassen, Katherine L. Lev, Michael J. Rybak
Published 2020-10-01

A three-tiered approach to address barriers to COVID-19 vaccine delivery in the Black community

by Jacinda C Abdul-Mutakabbir, Samuel Casey, Veatrice Jews, Andrea King, Kelvin Simmons, Michael D Hogue, Juan Carlos Belliard, Ricardo Peverini, Jennifer Veltman
Published 2021-06-01

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>

by Jacinda C. Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, Philip T. Maassen, Kyle Stamper, Zain Shiekh, Razieh Kebriaei, Ryan K. Shields, Mariana Castanheira, Keith S. Kaye, Michael J. Rybak
Published 2021-07-01